Next earnings date: 18 Aug 2025

LakeShore Biopharma Co., Ltd – NASDAQ:LSB

Add to watchlist

$0.832

-2.49

-75.02%

Market closed

Open in 2 days

+608.06%

month

+608.06%

quarter

Market Cap	60.86M
Enterprise value	N/A

P/E	N/A
EV/Sales	N/A
EV/EBITDA	N/A
Price/Sales	N/A
Price/Book	N/A
PEG ratio	N/A
EPS	N/A

Revenue	N/A
EBITDA	N/A
Income	N/A
Revenue Q/Q	N/A
Revenue Y/Y	N/A

Profit margin	0%
Oper. margin	0%
Gross margin	0%
EBIT margin	0%
EBITDA margin	N/A

Get more financial ratios!

Every financial ratio you might need
10 years history
Forward ratios (Analysts estimates)

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

LakeShore Biopharma Co., Ltd (NASDAQ:LSB): Profit margin
2023	687.20M	-145.47M	-21.17%
2024	573.41M	-433.46M	-75.59%

LakeShore Biopharma Co., Ltd (NASDAQ:LSB): Earnings per share (EPS)
2024-04-19	-0.09	-0.12
2024-09-24	-0.58	-1.34

LakeShore Biopharma Co., Ltd (NASDAQ:LSB): Debt to assets
2023	1719753611	991.30M	57.64%
2024	1513027356	927.82M	61.32%

LakeShore Biopharma Co., Ltd (NASDAQ:LSB): Cash Flow
2024	-295.22M	-44.25M	205.26M

LakeShore Biopharma Co., Ltd alternative data

LakeShore Biopharma Co., Ltd
Employees

LakeShore Biopharma Co., Ltd (NASDAQ:LSB): Employee count
Jun 2024	773
Jul 2024	773
Dec 2024	758

LakeShore Biopharma Co., Ltd
Latest News

Thursday, 19 December 2024
09:05	LakeShore Biopharma Reports Unaudited Financial Results for the First Half of Fiscal Year 2025 and Updates Full-Year Guidance	prnewswire.com
Thursday, 12 December 2024
19:57	LakeShore Biopharma Provides Update on Ongoing Criminal Investigation Involving Former Chairman in China	globenewswire.com
Tuesday, 3 December 2024
16:10	LSB Industries Announces Publication of 2023 Sustainability Report	businesswire.com
Monday, 11 November 2024
16:10	LSB Industries, Inc. Appoints John Chandler as an Independent Member of the Board of Directors	businesswire.com
Tuesday, 29 October 2024
16:10	LSB Industries, Inc. Reports Operating Results for the 2024 Third Quarter	businesswire.com
08:30	LakeShore Biopharma Regains Compliance with Nasdaq Minimum Bid Price Requirement	prnewswire.com
Friday, 25 October 2024
08:30	LakeShore Biopharma Granted Phase III Clinical Trial Approval to Explore Simplified Regimens for YSJA Rabies Vaccine	prnewswire.com
Thursday, 10 October 2024
16:05	LSB Industries, Inc. Schedules 2024 Third Quarter Financial Results Release for Tuesday, October 29th and Conference Call for Wednesday, October 30th	businesswire.com
Tuesday, 8 October 2024
08:30	LakeShore Biopharma Provides Fiscal Half Year 2025 Financial Guidance and Reaffirms Fiscal Year 2025 Financial Guidance	prnewswire.com
Friday, 27 September 2024
07:00	LakeShore Biopharma Announces Results of Extraordinary General Meeting on Share Consolidation	prnewswire.com
Tuesday, 10 September 2024
08:00	Lakeshore Biopharma to Hold an Extraordinary General Meeting of Shareholders on September 27, 2024	prnewswire.com
Wednesday, 4 September 2024
08:00	LakeShore Biopharma Announces Leadership Transitions	prnewswire.com
Thursday, 15 August 2024
08:30	LakeShore Biopharma Announces Financial Results for Fiscal Year 2024	prnewswire.com
Friday, 5 July 2024
07:00	LakeShore Biopharma to Hold an Extraordinary General Meeting on July 25, 2024, Pursuant to Shareholders' Requisition	prnewswire.com

Frequently Asked Questions (FAQ)

What's the price of LakeShore Biopharma Co., Ltd stock today?

One share of LakeShore Biopharma Co., Ltd stock can currently be purchased for approximately $0.83.
When is LakeShore Biopharma Co., Ltd's next earnings date?

LakeShore Biopharma Co., Ltd is estimated to report earnings on Monday, 18 Aug 2025.
Does LakeShore Biopharma Co., Ltd pay dividends?

No, LakeShore Biopharma Co., Ltd does not pay dividends.
How much money does LakeShore Biopharma Co., Ltd make?

LakeShore Biopharma Co., Ltd has a market capitalization of 60.86M and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 16.56% to 573.42M US dollars. LakeShore Biopharma Co., Ltd made a loss 433.46M US dollars in net income (profit) last year or -$1.34 on an earnings per share basis.
What is LakeShore Biopharma Co., Ltd's stock symbol?

LakeShore Biopharma Co., Ltd is traded on the NASDAQ under the ticker symbol "LSB".
What is LakeShore Biopharma Co., Ltd's primary industry?

Company operates in the Healthcare sector and Biotechnology industry.
How do i buy shares of LakeShore Biopharma Co., Ltd?

Shares of LakeShore Biopharma Co., Ltd can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
How many employees does LakeShore Biopharma Co., Ltd have?

As Dec 2024, LakeShore Biopharma Co., Ltd employs 758 workers, which is 2% less then previous month.
When LakeShore Biopharma Co., Ltd went public?

LakeShore Biopharma Co., Ltd is publicly traded company for more then 4 years since IPO on 5 Aug 2021.
What is LakeShore Biopharma Co., Ltd's official website?

The official website for LakeShore Biopharma Co., Ltd is ysbiopharm.com.
How can i contact LakeShore Biopharma Co., Ltd?

LakeShore Biopharma Co., Ltd can be reached via phone at +86 10 8920 2086.

LakeShore Biopharma Co., Ltd

ysbiopharm.com

Exchange:

NASDAQ

Full time employees:

758

Industry:

Biotechnology

Sector:

Healthcare

LakeShore Biopharma Co., Ltd, a biopharmaceutical company, engages in discovering, developing, manufacturing, and commercializing of vaccines and therapeutic biologics for infectious diseases and cancer. The company develops a proprietary PIKA immunomodulating technology platform and a series of product targeting PIKA rabies vaccine, PIKA recombinant COVID-19 vaccine, and PIKA YS-ON-001. It operates in China, the United States, Singapore, the United Arab Emirates, and the Philippines. The company was formerly known as YS Biopharma Co., Ltd. and changed its name to LakeShore Biopharma Co., Ltd in May 2024. LakeShore Biopharma Co., Ltd was founded in 2002 and is based in Beijing, China.

+86 10 8920 2086

Building No. 2
Beijing, 102629

:
ISIN: KYG9845F1090
: